| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |